Allogeneic bone marrow transplantation in hematologic disorders of childhood: New trends and controversies

Haematologica

Volumn 85, Issue 11 SUPPL., 2000, Pages 2-8

  Barth, E ^a   Malorgio, C ^a   Tamaro, P ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

ALL; Allogeneic bone marrow transplantation; AML; Childhood; CML; Hematologic disorders; HR ALL; Infancy; Myelodysplastic syndromes; Pediatric; Severe aplastic anemia; Sickle cell anemia; Thalassemia major

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHILDHOOD DISEASE; HUMAN; MYELODYSPLASTIC SYNDROME; QUALITY OF LIFE; SICKLE CELL ANEMIA; THALASSEMIA MAJOR;

BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; HEMATOLOGIC DISEASES; HUMANS;

EID: 0033694872     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Treatment of acute lymphoblastic leukaemia: 30 years experience at S. Jude Children's Hospital
2. Biology and treatment of acute lymphoblastic leukaemia
3. Indications for marrow transplantation in acute lymphoblastic leukaemia
4. Chemotherapy in 998 unselected childhood acute lymphoblastic leucemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
5. Good steroid response in vivo predicts a favourable outcome in children with T-cell acute lymphoblastic leucemia
6. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: Experience in MRC UKALL X
7. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia in first remission: A cooperative study of the Group d'Etude de la Greffe de Moelle Osseuse
8. Treatment of newly diagnosed children and adolescents with AML: A report form the Children's Cancer Group
9. Late effects of BMT for children with AML in first complete remission: The impact of conditioning regimen without total body irradiation - A report from the Societe Francaise de Greffe de Moelle
10. Late effects of intensive treatment for AML and MDS in childhood
11. Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience
12. The combined effect of TBI and CyA on the risk of relapse in patients with acute myeloid leukemia undergoing allogeneic bone marrow transplantation
13. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
14. Marrow transplantation For CML: The Seattle experience
15. Chronic myeloid leukemia: From biology to therapy
16. Myelodysplastic Syndromes in children. A critical review of the clinical manifestations and management
17. Severe aplastic anemia of neonatal onset: A single-center retrospective study of six children
18. Refractory anemia with ringed sideroblasts in children: Two disease with a similar phenotype?
19. Myelodysplasia and myeloprolipherative disorders in chidhood: An update
20. Occurrence of myeloproliferative disorder in patients with Noonan syndrome
21. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with MDS: Early transplantation is associated with improved outcome. Chronic Leukemia Working Party of European Group for Blood and Marrow transplantation
22. Myelodysplastic syndrome, juvenile myelomonocytic leukaemia, and AML associated with complete or partial monosomy 7. European Working Group on MDS in childhood (EWOG-MDS)
23. Improved prognosis for acquired aplastic anemia
24. The modern management of SAA
25. Aplastic anemia before BMT and ATG
26. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation
27. Multicenter randomized study comparing cyclosporin-A alone and ATG with prednisolone for treatment of severe aplastic anemia
28. Bone marrow transplantation for beta-thalassemia
29. Late effects of bone marrow transplantation for thalassemia
30. Bone marrow transplantation in thalassemia The experience of Pesaro
31. Second marrow transplants for graft failure in patients with Thalassemia
32. Early iron reduction programme for Thalassemia patients after BMT
33. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: A decision analysis
34. Impact of BMT for symptomatic sickle cell disease: An interim report
35. Barriers to bone marrow transplantation for sickle cell anemia
36. Results and current indications of bone marrow allograft in sickle cell disease